SNNUF News and Press, Smith & Nephew Plc Ord From 03/25/24

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has been named the Preferred Sports Medicine Technology Partner of UFC – the world’s premier mixed martial arts organization and one of the foremost global brands in all of sports. Under the t...

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announced they have entered into a Master Cooperative Research and Development Agreement (CRADA) with the U.S. Army Institute of Surgical Research (USAISR). This marks the first time that the USAISR has entered into a m...

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces full commercial availability of its AETOS Shoulder System in the US, along with 510(k) clearance for its use with ATLASPLAN ◊ 3D Planning Software and Patient Specific Instrumentation for total shou...

Smith+Nephew (LSE: SN, NYSE:SNN), the global medical technology company, announces it will provide a glimpse into the future at AAOS 2024. With a first opportunity to see a forthcoming new feature* for its CORI ◊ Surgical System, this exclusive image-agnostic* robotic-assisted surgical...

12 February 2024 Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces the premiere of its newly acquired CARTIHEAL ◊ AGILI-C ◊ Cartilage Repair Implant alongside the REGENETEN ◊ Bioinductive Implant at the AAOS Annual Meeting, de...

First published randomized controlled trial for market-leading implant demonstrates impressive outcomes for rotator cuff tears Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces standout results for its REGENETEN Bioinductive Implant from a recently comp...

2023-11-05 11:11:03 ET Smith & Nephew plc (SNN) Q3 2023 Earnings Conference Call November 2, 2023, 4:30 AM ET Company Participants Deepak Nath - Chief Executive Officer Anne-Francoise Nesmes - Chief Financial Officer Conference Call Participants Rober...

2023-10-12 16:31:15 ET Summary Smith & Nephew's shares have fallen over 20% this summer, despite ongoing improvements in the company's operations, as ortho stocks have been especially weak. The impact of GLP-1 drugs on the knee replacement market is uncertain; reduced obesity ...

2023-08-04 02:39:09 ET Smith & Nephew plc (SNN) Q2 2023 Earnings Conference Call August 3, 2023 03:30 ET Company Participants Deepak Nath - Chief Executive Officer Anne-Francoise Nesmes - Chief Financial Officer Conference Call Participants Jack Reyno...

2023-05-14 01:05:59 ET Summary Smith & Nephew has caught a 21% bid in the past 6 months despite no major fundamental changes. Long-term data analysis reveals the company's difficulty in turning capital investments into additional market valuation. Shares look to be fairly ...